AAFP: Payers indicate readiness for ICD-10

The largest private payers in the U.S. reported that they will be ready for ICD-10 implementation by the Oct. 1 compliance deadline, according to the American Academy of Family Physicians (AAFP).

The AAFP surveyed key contacts at large payers, including UnitedHealthcare, Aetna, BlueCross Blueshield and Humana, to ascertain their level of preparedness, list any problems or issues with testing, ensure the availability of contingency plans to tackle problem areas, ensure opportunities for multiple testing episodes for physician practices, among others.

The payers reported that they are working to ensure success with large clients first before moving on to readiness with smaller physician practices. Also, all payers established ICD-10 preparedness pages on their websites designed to assist physicians.

Overall, findings from the survey were positive, according to Laura Schmidt, an AAFP private sector advocacy strategist. "Insurers indicated that they'll be ready for the Oct. 1 ICD-10 deadline, and our members need to assume a sense of urgency to be ready as well," she said in a release.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.